Literature DB >> 23917471

Hemodynamic response to upright resistance exercise: effect of load and repetition.

Blake G Perry1, Zachary J Schlader, Matthew J Barnes, Darryl J Cochrane, Samuel J E Lucas, Toby Mündel.   

Abstract

INTRODUCTION/
PURPOSE: Upright resistance exercise causes large transient fluctuations in blood pressure during and immediately after the performance. We examined the effect of resistance load and the number of repetitions on the middle cerebral artery blood flow velocity (MCAv) response during and after upright squatting exercise.
METHODS: Healthy males (n = 12; mean ± SD: 26 ± 5 yr) completed 30%, 60%, and 90% of their six-repetition maximum load, completing two and six repetitions of these loads during two visits (order randomized). Beat-to-beat MCAv, blood pressure, and continuous end-tidal PCO2 during exercise, at nadir, and during recovery are reported as the change from preexercise standing baseline.
RESULTS: During exercise, MCAvmean increased 31% ± 16% (P < 0.001) across all loads (P = 0.74) and repetitions (P = 0.89), whereas mean arterial pressure (MAP) increased (all P < 0.05) as load and repetitions increased (e.g., 122 ± 9 (two repetitions) vs 135 ± 11 mm Hg (six repetitions) and 128 ± 13 vs 143 ± 14 mm Hg, at 30% and 60%, respectively). Within the six-repetition sets, peak MCAvmean remained unchanged across the set (P = 0.61), whereas MAP increased (P = 0.003). The 90% load produced the lowest MCAvmean nadir (pooled means, -18 ± 6 vs -10 ± 7 cm·s, P < 0.001 vs 30%) and MAP nadir (-34 ± 7 and -43 ± 5 mm Hg, for two and six repetitions, respectively; P < 0.001) after exercise. Postexercise MCAvmean reductions occurred via a selective, load-dependent (P < 0.001) decrease in diastolic MCAv. MCAvmean remained below baseline for the longest period after the 90% six-repetition set (10 s postexercise, P < 0.01) and took the longest to recover (14.8 ± 6.9 s, P = 0.002).
CONCLUSION: These data indicate that higher relative loads produce a greater postexercise hypotension and result in a proportionate reduction in MCAvmean.

Entities:  

Mesh:

Year:  2014        PMID: 23917471     DOI: 10.1249/MSS.0b013e3182a7980f

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

Review 1.  High-intensity interval exercise and cerebrovascular health: curiosity, cause, and consequence.

Authors:  Samuel J E Lucas; James D Cotter; Patrice Brassard; Damian M Bailey
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-01       Impact factor: 6.200

2.  Cerebrovascular, cardiovascular and strength responses to acute ammonia inhalation.

Authors:  Blake G Perry; Hayden J Pritchard; Matthew J Barnes
Journal:  Eur J Appl Physiol       Date:  2015-12-30       Impact factor: 3.078

Review 3.  Blood pressure regulation X: what happens when the muscle pump is lost? Post-exercise hypotension and syncope.

Authors:  John R Halliwill; Dylan C Sieck; Steven A Romero; Tahisha M Buck; Matthew R Ely
Journal:  Eur J Appl Physiol       Date:  2013-11-07       Impact factor: 3.078

4.  Influence of neurovascular mechanisms on response to tDCS: an exploratory study.

Authors:  Pooja C Iyer; Alexander Rosenberg; Tracy Baynard; Sangeetha Madhavan
Journal:  Exp Brain Res       Date:  2019-08-27       Impact factor: 1.972

5.  Interrepetition Rest Set Lacks the V-Shape Systolic Pressure Response Advantage during Resistance Exercise.

Authors:  Xian Mayo; Eliseo Iglesias-Soler; J Derek Kingsley; Xurxo Dopico
Journal:  Sports (Basel)       Date:  2017-12-01

Review 6.  The Acute Cardiorespiratory and Cerebrovascular Response to Resistance Exercise.

Authors:  Blake G Perry; Samuel J E Lucas
Journal:  Sports Med Open       Date:  2021-05-27

7.  Acute reduction in posterior cerebral blood flow following isometric handgrip exercise is augmented by lower body negative pressure.

Authors:  Takuro Washio; Jennifer R Vranish; Jasdeep Kaur; Benjamin E Young; Keisho Katayama; Paul J Fadel; Shigehiko Ogoh
Journal:  Physiol Rep       Date:  2018-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.